surmount trial tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 The big question with Mounjaro

Using the same spot repeatedly can cause lipohypertrophy (tissue lumps) that affect medication absorption

Certificate information is lot-specific

How many units is 5mg of tirzepatide

Scenario 2: Addressing Constipation and Dehydration Mark, another patient, struggled with constipation and fatigue

image credit- shutterstock The GLP-1 agonist market in India is poised for a significant transformation as Semaglutide, one of the most widely prescribed therapies for diabetes and weight management globally, is set to lose patent protection in mid-March 2026

GLP-1s have been approved for treatment of type 2 diabetes mellitus (T2DM) since 2005 and have also demonstrated high efficacy for weight loss (Jastreboff et al., 2022